„Ozempic natural”, descoperit cu ajutorul inteligenței artificiale

Researchers at Stanford Medicine have identified a natural molecule, BRP, which may lead to new obesity treatments. This peptide, discovered using AI, shows effects similar to Ozempic in reducing appetite and weight without significant side effects. BRP primarily targets the hypothalamus, potentially explaining the absence of common digestive issues seen with current medications. Animal studies indicate that a single injection can reduce food intake by up to 50%, with minimal muscle loss during weight reduction. Clinical trials are planned to further assess BRP's safety and efficacy in humans.